FDA inspection
Chongqing Pharscin Pharmaceutical Co., Ltd. (Banqiao Road): FDA inspection ending May 26, 2023
FDA inspection 1209318 · No Action Indicated (NAI) · Chongqing
Key facts
| Inspection ID | 1209318 |
|---|---|
| Firm | Chongqing Pharscin Pharmaceutical Co., Ltd. (Banqiao Road) |
| FEI number | 3022784615 |
| Address | No. 143 Banqiao Road, Changzhou Street, Rongchang |
| City | Chongqing |
| Fiscal year | 2023 |
| Inspection end date | May 26, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data